Financials
- Market Capitalization 5.75 B
- Employee 370
- Founded 1996
- CEO N/A
- Website www.xenon-pharma.com
- Headquarter British Columbia, Canada
- FIGI BBG0073DM784
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.73
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1246 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 103.58 USD | -2.14% | -5.77% | -1.95% | +342.84% | 5.79 B USD | ||
| 1252 | PTCT PTC Therapeutics, Inc. - Common Stock | 69.16 USD | -1.33% | -0.83% | +2.95% | +39.80% | 5.77 B USD | ||
| 1278 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 277.79 USD | -0.96% | -1.96% | -3.26% | +48.46% | 5.54 B USD | ||
| 1282 | DFTX Definium Therapeutics, Inc. - Common Shares | 40.98 USD | -6.48% | -6.33% | -4.41% | +171.21% | 5.51 B USD |